Suppr超能文献

[半乳糖凝集素-7和S100A9的表达与宫颈鳞状细胞癌的发展]

[Expression of galectin-7 and S100A9 and development of cervical squamous carcinoma].

作者信息

Zhu Hong, Liu Li, Liu Huan, Wu Tiancong, Wu Yue, Zeng Shan, Zeng Liang

机构信息

Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008,China.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Sep;38(9):888-95. doi: 10.3969/j.issn.1672-7347.2013.09.004.

Abstract

OBJECTIVE

To observe the correlation between the expression of galectin-7 and S100A9 with the development of cervical squamous carcinoma.

METHODS

Immunohistochemical SP staining was used to detect the expression of galectin-7 and S100A9 in 243 patients with cervical intraepithelial neoplasia (CIN) or cervical squamous carcinoma. The association of clinical data with galectin-7 and S100A9 expression was examined.

RESULTS

The expression of galectin-7 and S100A9 in CIN and cervical squamous carcinoma was significantly different (P<0.05). The positive rates of galectin-7 in normal cervical tissues, CIN I, CIN II, CIN III, and cervical squamous carcinoma were 56.7%, 41.9%, 32.0%, 27.3%, and 25.0%, respectively. Statistic analysis found significant difference between the normal cervical tissues and cervical squamous carcinoma (P<0.0045). The positive rates of S100A9 in CIN I, CIN II, CIN III, and cervical squamous carcinoma were 80.0%, 77.4%, 48.0%, 27.3%, and 20.2%. Statistic analysis showed significant difference between the normal tissues and CIN III, the normal cervical tissues and cervical squamous carcinoma, CIN I and CIN III, CIN I and cervical squamous carcinoma, CIN II and cervical squamous carcinoma (P<0.0045). A positive correlation was found between galectin-7 and S100A9 expression in CIN and cervical squamous carcinoma (rs=0.298, P<0.001). Expressions of both galectin-7 and S100A9 in cervical squamous carcinoma were associated with the clinical stage and lymph nodes (P<0.05), but not with patient's age and degree of differentiation (P>0.05). Expression of galectin-7 was associated with the survival rate of patients with cervical squamous carcinoma (P<0.05). Univariate analysis of Cox proportional hazards regression model revealed that the FIGO stage, lymph nodes metastasis, and the expression of galectin-7 were relevant to the 5 year survival rate of patients with cervical squamous carcinoma, which was confirmed by multiple analysis of Cox proportional hazards regression model.

CONCLUSION

Expression of galectin-7 and S100A9 is related with cervical the tumorigenesis of carcinoma, clinical stage, and lymph nodes of cervical squamous carcinoma. Galectin-7 is probably associated with the prognosis. The long-term survival of patients with cervical carcinoma may be associated with FIGO stage, lymph node metastasis, and the expression of galectin-7.

摘要

目的

观察半乳糖凝集素-7(galectin-7)和S100A9的表达与宫颈鳞状细胞癌发生发展的相关性。

方法

采用免疫组织化学SP染色法检测243例宫颈上皮内瘤变(CIN)或宫颈鳞状细胞癌患者中galectin-7和S100A9的表达情况,并分析临床资料与galectin-7和S100A9表达的相关性。

结果

galectin-7和S100A9在CIN和宫颈鳞状细胞癌中的表达差异有统计学意义(P<0.05)。galectin-7在正常宫颈组织、CIN I、CIN II、CIN III及宫颈鳞状细胞癌中的阳性率分别为56.7%、41.9%、32.0%、27.3%和25.0%。统计学分析显示正常宫颈组织与宫颈鳞状细胞癌之间差异有统计学意义(P<0.0045)。S100A9在CIN I、CIN II、CIN III及宫颈鳞状细胞癌中的阳性率分别为80.0%、77.4%、48.0%、27.3%和20.2%。统计学分析表明正常组织与CIN III、正常宫颈组织与宫颈鳞状细胞癌、CIN I与CIN III、CIN I与宫颈鳞状细胞癌、CIN II与宫颈鳞状细胞癌之间差异有统计学意义(P<0.0045)。在CIN和宫颈鳞状细胞癌中,galectin-7与S100A9的表达呈正相关(rs=0.298,P<0.001)。galectin-7和S100A9在宫颈鳞状细胞癌中的表达均与临床分期及淋巴结转移有关(P<0.05),但与患者年龄及分化程度无关(P>0.05)。galectin-7的表达与宫颈鳞状细胞癌患者的生存率有关(P<0.05)。Cox比例风险回归模型单因素分析显示,国际妇产科联盟(FIGO)分期、淋巴结转移及galectin-7的表达与宫颈鳞状细胞癌患者的5年生存率相关,Cox比例风险回归模型多因素分析证实了这一点。

结论

galectin-7和S100A9的表达与宫颈鳞状细胞癌的发生、临床分期及淋巴结转移有关。galectin-7可能与预后相关。宫颈癌患者的长期生存可能与FIGO分期、淋巴结转移及galectin-7的表达有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验